Related Experiment Video
Updated: Nov 23, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
COVID-19 myocarditis and long-term heart failure sequelae
Jing Liu1, Anita Deswal2, Umair Khalid3
1Section of Cardiology, Department of Medicine, Baylor College of Medicine.
Insights
Coronavirus disease 2019 (COVID-19) can cause myocarditis and long-term heart failure. Early diagnosis and treatment are crucial for managing cardiac dysfunction in COVID-19 patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathology
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic.
- Cardiac dysfunction and heart failure are common complications in COVID-19 patients.
- Myocardial involvement in COVID-19 requires careful evaluation.
Purpose of the Study:
- To provide a comprehensive review of COVID-19 myocarditis.
- To discuss the long-term heart failure sequelae associated with COVID-19.
- To explore diagnostic and therapeutic strategies for COVID-19-related cardiac dysfunction.
Main Methods:
- Review of existing literature on COVID-19 myocarditis.
- Analysis of clinical presentations and diagnostic findings.
- Evaluation of treatment strategies and outcomes.
Main Results:
- COVID-19 can lead to a spectrum of ventricular dysfunction, including myocarditis.
- Distinguishing myocarditis from other causes of cardiac dysfunction (e.g., cytokine storm, microvascular thrombosis) is challenging.
- Myocardial dysfunction in COVID-19 is associated with poor prognosis.
Conclusions:
- Timely diagnosis of COVID-19 myocarditis is essential, utilizing laboratory tests, echocardiography, cardiac MRI, and potentially endomyocardial biopsy.
- Management involves supportive care and targeted therapies.
- Further research is needed to determine the prevalence of COVID-19 myocarditis and refine diagnostic and treatment protocols.
Purpose Of Review:
The clinical syndrome of coronavirus disease 2019 (COVID-19) has become a global pandemic leading to significant morbidity and mortality. Cardiac dysfunction is commonly seen in these patients, often presenting as clinical heart failure. Accordingly, we aim to provide a comprehensive review on COVID-19 myocarditis and its long-term heart failure sequelae.
Recent Findings:
Several suspected cases of COVID-19 myocarditis have been reported. It is often not clear if the acute myocardial dysfunction is caused by myocarditis or secondary to generalized inflammatory state of cytokine release or microvascular thrombotic angiopathy. Ischemia may also need to be ruled out. Regardless, myocardial dysfunction in these patients is associated with poor overall prognosis. Laboratory testing, echocardiography, cardiac magnetic resonance imaging, and even endomyocardial biopsy may be needed for timely diagnosis. Several treatment strategies have been described, including both supportive and targeted therapies.
Summary:
COVID-19 can cause a spectrum of ventricular dysfunction ranging from mild disease to fulminant myocarditis with hemodynamic instability. Future research is needed to understand the true prevalence of COVID-19 myocarditis, as well as to better define various diagnostic protocols and treatment strategies.
More Related Videos
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
10:21Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis IV: Nursing Management
Mitral Regurgitation I: Introduction